Cécile Thébault
Director/Board Member chez Invers SA
Profil
Cécile Thébault is an Investment Director at Sofimac Régions SAS since 2010.
She is also a Member-Supervisory Board at Invers SA since 2019.
Previously, she held positions as a Director at Imaxio SA, ImmunID SAS, Biom'Up SA, Afyren SAS, and Theranexus SA. Ms. Thébault completed her undergraduate degree at Ecole Supérieure de Commerce de Clermont-Ferrand.
Postes actifs de Cécile Thébault
Sociétés | Poste | Début |
---|---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Investment Committee Member | 22/06/2010 |
Invers SA
Invers SA Agricultural Commodities/MillingProcess Industries Invers SA engages in the provision of sustainable animal feed and fertilization. It offers dog, cat, bird food, and natural fertilizer. The company was founded by Sebastien Crepieux, Stéphanie Cailloux, David Quittard, and Ludovic Tournier in March 2018 and is headquartered in Saint-Beauzire, France. | Director/Board Member | 28/06/2019 |
Anciens postes connus de Cécile Thébault
Sociétés | Poste | Fin |
---|---|---|
AFYREN | Director/Board Member | - |
BIOM'UP | Director/Board Member | - |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Director/Board Member | - |
THERANEXUS | Director/Board Member | - |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Director/Board Member | - |
Formation de Cécile Thébault
Ecole Supérieure de Commerce de Clermont-Ferrand | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
THERANEXUS | Health Technology |
AFYREN | Health Technology |
Entreprise privées | 5 |
---|---|
Sofimac Régions SAS
Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Finance |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Health Technology |
Biom'Up SA
Biom'Up SA Medical SpecialtiesHealth Technology Biom'Up SA engages in the development of hemostatic product composed of patent-protected biopolymers. Its products include Hemoblast Bellows and Hemosnow. The company was founded by Patricia Forest, Sylvain Picot and Christian Gagnieu on February 21, 2005 and is headquartered in Lyon, France. | Health Technology |
Invers SA
Invers SA Agricultural Commodities/MillingProcess Industries Invers SA engages in the provision of sustainable animal feed and fertilization. It offers dog, cat, bird food, and natural fertilizer. The company was founded by Sebastien Crepieux, Stéphanie Cailloux, David Quittard, and Ludovic Tournier in March 2018 and is headquartered in Saint-Beauzire, France. | Process Industries |